Back to Blog
Fluttering heartbeat necklace5/4/2023 Q&A on self-monitoring ECG necklace How does the user measure their heart rate with the device? Helena Jäntti, Heart2Save CEO and emergency doctor at Kuopio University Hospital, Finland, discusses her company’s device, and its potential in the field of at-home heart monitoring. Heart2Save is currently in the process of gaining a CE marking to sell the necklace in Europe and is aiming to reach this goal by Q4 2020. When compared to the gold standard for ECG monitoring, the necklace was also found to accurately detect and diagnose atrial fibrillation (AF) - a condition characterised by an irregular heartbeat rhythm, which is often unrecognised and causes approximately 25% of strokes. The device connects to Heart2Save’s mobile phone app, AiVoni, to analyse results from the monitor.Įvidence of the device’s effectiveness was recently published online by the European Society of Cardiology (ESC), which described it as “ingenious”, and found it was able to produce “excellent quality” ECG (electrocardiogram) recordings in a study involving 145 participants. Heart2Save has described this as “the starting point for a new era of self-monitoring”. The necklace is designed to monitor a patient’s heartbeat in a subtle, fashionable way that doesn’t highlight they have a heart condition. The firm worked with fellow Finnish company and jewellery maker Lumoava to create the AiVoni Lumoava device. Medtech start-up Heart2Save has developed a product it claims will “revolutionise” heart rhythm self-monitoring - an AI-powered ECG necklace. The ECG necklace developed by Finnish company Heart2Save is said to enable self-monitoring of a patient's heart rate using a subtle piece of jewelleryĪ study published online by the European Society of Cardiology described the necklace as "ingenious"
0 Comments
Read More
Leave a Reply. |